More Details on This News

Cupid Limited anticipates its strongest quarter to date in Q3 FY26, driven by robust demand and efficient operations. The company has achieved its highest-ever order book, providing strong visibility for future performance. Management is confident in exceeding the FY26 guidance of ₹335 crore in revenue and ₹100 crore in PAT.

Capacity expansion at the Palava, Maharashtra facility is progressing as planned. The FMCG business is gaining traction in India with positive consumer response to recently launched products like Petroleum Jelly, Face Wash, and Talcum Powder.

Strategically, Cupid is expanding its presence in the GCC region. Following board approval on December 29, 2025, a proposed FMCG manufacturing facility in Saudi Arabia is targeted for completion by March 2027, subject to regulatory approvals. This facility aims to serve regional demand and improve supply timelines in the GCC and nearby export markets.

The company benefits from the prevailing INR environment and does not foresee significant impact from trade developments. Key international certifications for its products, including IVD kits and condoms, along with expected WHO prequalification, will bolster international market growth. Cupid's investment in GII Healthcare Investment Limited Fund has appreciated to 1.2x its initial value.

Mr. Aditya Kumar Halwasiya, Chairman and Managing Director, expressed confidence in surpassing FY26 guidance, highlighting the encouraging momentum and progress in expansion initiatives, including the Saudi FMCG facility, which aligns with building a diversified growth platform.